StudyID: DIAMOND 2001 (subordinated publication), atrial fibrillation, persistent
DISEASE INTERVENTION COMPARISON RESULTS
Ugeskr Laeger. 2000 Oct 30;162 (44);5948-53 Randomized Controlled Trial
IN StudyID: DIAMOND 2001 (subordinated publication), atrial fibrillation, persistent The Use of
dofetilide
As Treatment, Chronic
Is better Than
placebo
To mortality, FA recurrence, rehospitalization, heart failure - at 1 year
N Engl J Med. 1999 Sep 16;341(12):857-65 Randomized Controlled Trial, Multicenter Trial
IN StudyID: DIAMOND 2001 (subordinated publication), atrial fibrillation, persistent The Use of
dofetilide
As Treatment, Chronic
Is better Than
placebo
To mortality, FA recurrence, rehospitalization, heart failure - at 18 months
Congest Heart Fail. 2001 May-Jun;7(3):146-150 Randomized Controlled Trial, Multicenter Trial
IN StudyID: DIAMOND 2001 (subordinated publication), atrial fibrillation, persistent The Use of
dofetilide
As Treatment, Chronic
Is better Than
placebo
To mortality, FA recurrence, rehospitalization because heart failure, adverse effects, proarythmia - at 12 months